Clinical application of pulsatile perfusion during cardiopulmonary bypass in pediatric heart surgery

Ju Zhao1, Jin-ping Liu, Zheng-yi Feng

  • 1Departments of Cardiopulmonary Bypass, Fuwai Hospital and Cardiovascular Institution, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, People's Republic of China. zhaojucpb@hotmail.com

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|March 14, 2009
PubMed

Insights

Pulsatile perfusion in pediatric cardiac surgery reduces inflammatory markers compared to nonpulsatile perfusion. This study shows benefits for congenital heart disease patients undergoing open heart surgery.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Biomedical Engineering

Background:

  • The use of pulsatile versus nonpulsatile perfusion during cardiopulmonary bypass (CPB) in pediatric cardiac surgery remains a topic of debate.
  • Congenital heart disease (CHD) in pediatric patients presents unique challenges during open heart surgery.

Purpose of the Study:

  • To evaluate the effectiveness of pulsatile perfusion (PP) compared to nonpulsatile perfusion (NP) in pediatric patients with congenital heart disease undergoing open heart surgery.
  • To assess the impact of PP on hemodynamic status and inflammatory markers.

Main Methods:

  • A randomized study involving 24 pediatric patients with tetralogy of Fallot (TOF).
  • Patients were divided into two groups: pulsatile perfusion (PP) and nonpulsatile perfusion (NP) groups.
  • Hemodynamic status and inflammatory markers (IL-8, TNF-alpha, free plasma hemoglobin) were monitored over time.

Main Results:

  • Pulsatile perfusion was successfully implemented, with significantly higher pulse pressure (DeltaP) in the PP group (p < 0.01).
  • Inflammatory markers (IL-8, TNF-alpha) were lower in the PP group post-cross-clamp and during the intensive care unit period.
  • Free plasma hemoglobin levels were higher in the PP group at pre-clamp off and CPB weaned off (p < 0.05).

Conclusions:

  • Pulsatile perfusion is a viable technique for pediatric cardiac surgery.
  • PP demonstrates a role in mitigating the concentration of inflammatory mediators in pediatric patients undergoing CPB.

Related Concept Videos